Medical vial and injector assemblies and methods of use

ABSTRACT

A medical liquid vial is disclosed with a resilient inner bladder and a pre-stress member located with the bladder. Injector assemblies are also disclosed for injecting the vial contents into a patient by advancing the vial through a series of stages or positions. Methods of filling and use are also disclosed.

RELATED APPLICATION

This application claims the benefit of and priority to U.S. ProvisionalPatent Application Ser. No. 61/704,922, filed Sep. 24, 2012, thecontents of which are incorporated by reference herein.

FIELD OF DISCLOSURE

This disclosure relates generally to vials for medical liquids, such asdrugs, antibiotics, or other liquids for medical therapeutic ordiagnostic purposes, and to injection apparatus for injecting the vialcontents. More specifically, this subject matter relates to such vials,which can be pre-filled with medical liquid and that can expelsubstantially all the contents, preferably at a generally constant flowrate, and to injection apparatus or assemblies for use with such vialsand to methods of filling and using such vials and apparatus.

The description below is directed to specific exemplary embodiments forthe purposes of illustration and not limitation. The features describedherein may be employed in other configurations or designs withoutdeparting from the scope of this disclosure. PCT InternationalPublication No. WO 2011/123569 A1 is hereby incorporated by referenceherein.

BRIEF DESCRIPTION OF DRAWINGS

FIG. 1 is a cross-sectional view of a preferred embodiment of thepresent invention. In this view, the vial assembly is shown in theunfilled state.

FIG. 2 is a cross-sectional view of a preferred embodiment of thepresent invention. In this view, the vial assembly is shown in thefilled state.

FIGS. 3-4 are cross-sectional views of the vial assembly being filledwith a syringe and vial adapter. The vial assembly is shown in theunfilled state in

FIG. 3 and shown in the filled state in FIG. 4.

FIG. 5 is a perspective view of the preferred embodiment of the presentinvention. In this view the filled vial assembly is being inserted intothe injector assembly.

FIG. 6 is cross-sectional view of FIG. 5.

FIGS. 7-14 are cross-sectional views of the preferred embodiment of thepresent invention of the injector assembly with vial assembly in placeshowing different sequences during the injection.

FIG. 15 is a perspective view of the preferred embodiment of the presentinvention of the injector assembly being removed from the injectionsurface after delivery of the liquid.

FIG. 16 is a perspective view of an alternative embodiment. In this viewthe filled vial assembly is being inserted into the injector assembly.

FIG. 17 is cross-sectional view of FIG. 16.

FIGS. 18-22 are cross-sectional views of an alternative embodiment ofthe injector assembly with vial assembly in place showing differentsequences during the injection.

FIG. 23 is a perspective view of an alternative embodiment of theinjector assembly being removed from the injection surface afterdelivery of the liquid.

FIG. 24 is a perspective view of an alternative embodiment of aninjector assembly. In this view the filled vial assembly is beinginserted into the injector assembly.

FIG. 25 is cross-sectional view of FIG. 24.

FIGS. 26-29 are cross-sectional views of an alternative embodiment ofthe injector assembly with vial assembly in place showing differentsequences during the injection.

FIG. 30 is a perspective view of an alternative embodiment of theinjector assembly being removed from the injection surface (e.g.patient's skin) after delivery of the liquid.

FIG. 31 is a perspective view of a vial such as in FIG. 1 and a fillingapparatus or spike for introducing medical liquid into the vial.

FIG. 32 is a cross-sectional perspective view of the vial of FIG. 31with filling apparatus fully inserted.

FIG. 33 is a cross-sectional perspective view of the vial of FIG. 32,with the filling apparatus partially withdrawn or partially inserted.

FIG. 34 is a cross-sectional perspective view of the vial of FIG. 33,with the filling apparatus further withdrawn or less inserted.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENT

Referring to FIG. 1, the vial assembly 5 may include a vial 1, outerstopper/bladder 2, inner plug 3 and crimp cap 4. The vial 1 may beconstructed from glass or plastic and range in volume from 1 mL to 10mL. The crimp cap 4 can be constructed from plastic, aluminum or steeland may include an optional pop-off safety tab. The crimp cap 4 couldfit a range of vial neck sizes from 13 to 32 mm in diameter. The outerstopper/bladder 2 (also known as the outer expanding element or balloon)and inner plug 3 can be made from blended synthetic rubber. They mayalso be independently different materials. This could include one ormore of the following in different concentrations: bromobutyl,chlorobutyl, isoprene, polyisoprene, SBR, polybudtadiene, EPDM, naturalrubber and silicone. In addition, these rubber components can be coatedto improve their surface properties. Coatings may include parylene,silicone, teflon and flourine gas treatments. Alternatively, the outerstopper/bladder 2 and inner plug 3 may be made from a thermoplasticelastomer. The outer stopper/bladder 2 may have irregular wall thicknessboth in the axial and circumferential direction including ribs orgrooves to provide intended variations in stress as a function ofstrain. This would allow for control over the pressure profile tocontrol the delivery flow rate as a function of diameter extension.

The assembly of the vial 1 may include a sub-assembly of the inner plug3 and outer stopper/bladder 2 prior to insertion into the vial 1.Alternatively, the outer stopper/bladder 2 can be assembled into thevial 1 and then the inner plug 3 assembled into the outerstopper/bladder 2. Once the outer stopper/bladder 2 and inner plug 3assembly are placed into the vial 1, the crimp cap 4 is placed onto thevial 1. The crimp force applied by the crimp cap 4 can be varied toachieve different compression forces on the outer stopper/bladder 2 andinner plug 3 assembly. This may allow for control of the sealperformance or venting function. The inner plug 3 is configured or sizedto provide a pre-stress on the outer stopper/bladder 2 to control thepressure profile as well as to aid in delivery of all or substantiallyall of the liquid contained within the outer stopper/bladder 2,preferably at about a constant flow rate for most of the injection. Apre-stress between the inner plug 3 and outer stopper/bladder 2 can becreated by making the outer diameter of the inner plug 3 larger thaninner diameter of the outer stopper/bladder 2. The inner plug 3 could bea solid piece of material or could be expandable element to control theamount of pre-stress. Gas or liquid could be introduced into a voidformed within the inner plug 3 to change its outer diameter or lengththus causing varying amounts of pre-stress. Alternatively oradditionally, pre-stress can be created by making the inner plug 3longer than the outer stopper/bladder 2.

Referring to FIG. 2, liquid 18 is contained within a space formedbetween the inner plug 3 and outer stopper/bladder 2. The outerstopper/bladder 2 expands like a balloon and applies a uniform pressureon the liquid 18 within this space 2. The shape of the outerstopper/bladder 2 when filled can be spherical or cylindrical.Cylindrical shapes allow for the same stresses as presented in aspherical shape but with more volume. When the vial assembly 5 iscoupled with an injector assembly, the pressure exerted by the outerstopper/bladder 2 on the liquid 18 allows for flow of the liquid 18 outof the vial assembly 5 through the needle of the injector assembly intothe patient. The outer stopper/bladder 2 is configured with a ring 6 toprovide a seal against the inside of the vial 1. The inner plug 3 andouter stopper/bladder 2 are configured to fit together to providemultiple seals between the inner plug 3 and outer stopper/bladder 2.Seals 17 may be configured in a tongue-and-groove or other interlockingsystem to provide a sealing function. Alternatively or additionally, aseal 17 is provided by the compression of the crimp cap 4 on the innerplug 3 and outer stopper/bladder 2 against the vial 1. Alternatively oradditionally, a seal may be formed by the interference between the innerplug 3 and outer stopper/bladder 2.

Referring to FIGS. 3 and 4, filling of the vial assembly 5 with liquid18 can be performed by the user or by filling equipment. A user filledsystem may include the vial assembly 5 connected to a vial adapter 28and syringe 26. The syringe 26 and vial adapter 28 is assembled to anempty vial assembly 5. The spike on the vial adapter 28 pierces thesolid rubber section of the inner plug 3. The liquid 18 is manuallytransferred to the vial assembly 5 between the outer stopper/bladder 2and the inner plug 3 by the user depressing the plunger 27 of thesyringe 26 causing the outer stopper/bladder 2 to inflate like aballoon. Once the liquid 18 is transferred to the outer stopper/bladder2, the syringe 26 and vial adapter 28 are removed. This would beconsidered filling under liquid pressure. Alternatively, a vacuum couldbe formed in the space between the outer stopper/bladder 2 and inside ofthe vial 1 causing the expansion of the outer stopper/bladder 2 toprepare it for receiving liquid. This would be considered filling underno liquid pressure.

Referring to FIGS. 5 and 6, the injector assembly 6 for injecting thecontents of the vial assembly 5 described earlier preferably, but notexclusively, includes a vial holder 7, needle hub 8, needle 25, adhesive9, outer housing 10, safety pin 11, double-sided tape 12, bandage 13 andouter bandage cover 14. Additionally, the injector assembly 6 could havethe vent needle 15. The vial holder 7 allows for containment of the vialassembly 5 and interfaces with the needle hub 8, outer housing 10 andsafety pin 11. There are cutouts 19 in the side of the vial holder 7 toallow for viewing of the vial assembly 5. Alternatively, the vial holder7 may have transparent viewing windows. This allows for viewing the vialassembly 5 to confirm the proper dose has been delivered. The needle hub8 allows for containment of the needle 25 and interfaces with the vialholder 7, adhesive 9 and inner plug 3. The needle hub 8 can moverelative the vial holder 7 and inner plug 3 and allows for communicationof the needle 25 with the liquid 18 in the outer stopper/bladder 2during dispense. The needle hub 8 may also have the ability forrotational movement to dislocate the needle 25 during removal of theinjector assembly 6 for needle stick safety. The needle 25 interfaceswith the adhesive 9, needle hub 8, bandage 13 and inner plug 3. Theneedle 25 pierces the solid rubber portion of the inner plug 3 to allowfor communication of the liquid 18 contained within the outerstopper/bladder 2 during dispense. The needle 25 pierces the bandage 13during activation of the injector assembly 6 prior to dispense of theliquid. The needle 25 inner diameter and length combined with theperformance characteristics of the vial assembly 5 allow for control ofthe flow rate of the liquid during dispense. The adhesive 9 is used tobond the needle 25 to the needle hub 8. This adhesive 9 could be forexample, epoxy or cyanoacrylate and be air, moisture or UV cured.

The outer housing 10 interfaces with the vial holder 7, needle hub 8,safety pin 11 and double-sided tape 12. It provides the means to locatethe injector assembly 6 onto the skin surface. The safety pin 11prevents inadvertent advancement of the vial holder 7 relative to theouter housing 10 prior to intended use of the injector assembly 6. Thesafety pin 11 interfaces with the outer housing 10 and vial holder 7.The safety pin 11 can be configured to allow for radial and rotationalmovement relative to the outer housing 10. The double-sided tape 12allows for attachment of the outer housing 10 to the skin surface. Italso holds the bandage 13 to the outer housing 10 until the outerhousing 10 is removed from the skin surface. The bandage 13 allows forwound protection after the injector assembly 6 is removed from the skinsurface. The bandage 13 interfaces with the outer housing 10,double-sided tape 12 and the outer bandage cover 14. The adhesion forcebetween the bandage 13 and the skin surface is greater than the adhesionforce between the bandage 13 and the double-sided tape 12. This allowsfor removal of the injector assembly 6 from the skin surface withoutremoval of the bandage 13. The double-sided tape 12 interfaces with theouter housing 10, bandage 13 and outer bandage cover 14. The outerbandage cover 14 provides for protection of the bandage 13 anddouble-sided tape 12 prior to use of the injector assembly 6. The outerbandage cover 14 is removed prior to use of the injector assembly 6 andinterfaces with the double-sided tape 12 and bandage 13.

Referring to FIGS. 7-9, the vial assembly 5 is inserted into theinjector assembly 6 until snaps 24 in the vial holder 7 interface withthe crimp cap 4 on the vial assembly 5 to prevent it from being removed.The top of the vial assembly 5 may be flush with the top of the vialholder 7 allowing for one method of verification that the vial assembly5 is sufficiently inserted into the injector assembly 6. The vial holder7 or vial assembly 5 cannot advance relative to the outer housing 10 asthe safety pin 11 keeps them from advancing. Cutouts 19 in the vialholder 7 allow the user to view the inside of the vial assembly 5. InFIG. 8, the outer bandage cover 14 is removed from the bottom of theinjector assembly 6. It is ready to be attached to the skin surface 16.In FIG. 9, the injector assembly 6 can be attached to the skin surface16. The double-sided tape 12 will provide the adhesion force between theouter housing 10 and the skin surface 16.

Referring to FIGS. 10-12, once the injector assembly 6 is place on theskin surface 16, the safety pin 11 is removed from the injector assembly6 and it is ready for actuation. Detent features 21 in the vial holder 7and outer housing 10 prevent the vial holder 7 from moving relative tothe outer housing 10 without user intervention. In FIG. 11, the userpushes down on the vial holder 7 to begin inserting the needle 25 intothe skin surface 16. Ramp features (over-center mechanism) 22 in thevial holder 7 and outer housing 10 allow for relatively small appliedforce by the user to produce a relatively large axial movement of thevial holder 7 into the outer housing 10. Axial movement of the vialholder 7, vial assembly 5, needle hub 8 and needle 25 (in unison)continues until the needle hub 8 bottoms out on the outer housing 10. InFIG. 12, the needle 25 and needle hub 8 motion stop relative to theouter housing 10 just before the needle 25 is in communication with thefluid in the outer stopper/bladder 2. While a latch/lockout 23 releasesthe vial holder 7 for an additional small movement to allow the needle25 to pierce the solid section of the inner plug 3 and allowingcommunication of the needle 25 with the liquid in the outerstopper/bladder 2. The latch/lockout 23 allows for complete needle 25travel into the skin surface 16 before the start of dispense. The needle25 enters the liquid space within a cutout 19 in the inner plug 3. Thissmall amount of motion also allows the vent needle 15 to pierce the wallof the outer stopper/bladder 2 to allow for venting of the space betweenthe outer stopper/bladder 2 and the inside of the vial 1.

Referring to FIGS. 13-15, once the needle 25 is in communication withthe liquid, substantially all of the liquid (preferably more than 95%and more preferably 99%) within the outer stopper/bladder 2 is dispensedinto the user. Cutouts 19 in the vial holder 7 allow the user tovisually confirm the entire amount of liquid was dispensed. In FIG. 14,the dispense is completed and the user begins to remove the injectorassembly 6 by pulling up on the vial holder 7. The adhesion forcebetween the double-sided tape 12 and the skin surface 16 holds the outerhousing 10 to the skin surface 16. Axial movement of the vial holder 7,vial assembly 5, needle hub 8 and needle 25 (in unison) continuesrelative to the outer housing 10 until the needle 25 is completelyretracted into the outer housing 10, shielding it from the user. Onceinside the outer housing 10, the needle 25 may be deflected to a storedposition that prevents reuse and protects against accidental needlestick by the user. For example, snaps 20 in the outer housing 10interface with the needle 25 and needle hub 8 to move it off center,slightly bending it and locking it out from being actuated again whilealso providing for additional needle shielding from the user. At the endof the vial holder 7 travel within the outer housing 10, the injectorassembly 6 is pulled away from the skin surface 16. The bandage 13 peelsaway from the outer housing 10 and is left behind on the skin surface16.

Detailed Description of Alternative Embodiments

Referring to FIGS. 16-17, in this embodiment, the vial holder and outerhousing are preferably one piece, with an upper vial holder and lowerbase for contacting the skin of the patient. These upper and lowerhousing portions are hinged along an annular junction along the outerperimeter of the outer housing. The needle hub 8 can be separate orconfigured as part of the vial holder/outer housing 17. The vialassembly 5 is inserted into the injector assembly 6 until snaps 17 inthe vial holder/outer housing 7 interface with the crimp cap 4 on thevial assembly 5 to prevent it from being removed. In this embodiment,the vial access end of the needle 3 is in communication with the liquid(drug, antibiotic or other medicament) 18 when the vial assembly 5 isinserted into the injector assembly 6. The injection end of the needle 3is embedded in an elastomeric needle shield 10 which prevents liquid 9from coming out of the needle 3. The vial assembly 5 cannot advancerelative to the vial holder/outer housing 7 as the safety pin 11 keepsthem from advancing. The injector assembly 6 is also covered with anouter bandage cover 14.

Referring to FIGS. 18-19, the outer bandage cover 14 and safety pin 11is removed from the injector assembly 6 and it is ready for actuation.In FIG. 19, the injector assembly 6 can be attached to the skin surface16. The double-sided tape 12 will provide the adhesion force between thecontact surface 15 of the vial holder/outer housing 7 and the skinsurface 16.

Referring to FIGS. 20-21, when the user attaches the injector assembly 6to the skin surface 16, the contact surface 15 of vial holder/outerhousing 7 is designed to flex into the injector assembly 6, providingfor an over-center action to produce a relatively large axial movementof the contact surface 15 into the holder/outer housing 7. Axialmovement of the contact surface 15 of vial holder/outer housing 7relative to the vial assembly 5, needle hub 8 and needle 3 continuesuntil the needle hub 8 bottoms out on the vial holder/outer housing 7.Additionally, the needle 3 passes through the needle shield 10 allowingfor flow of the liquid 9 out of the needle 3 into the skin surface 16.Additionally, this axial movement allows for complete needle travel intothe skin surface 16. In FIG. 21, substantially all of the liquid 9(preferably more than 95% and more preferably 99%) within the outerstopper/bladder 2 is dispensed into the user.

Referring to FIGS. 22-23, the dispense is completed and the user beginsto remove the injector assembly 6 by pulling up on the vial holder/outerhousing 7. The adhesion force between the double-sided tape 12 attachedto the contact surface 15 of the vial holder/outer housing 7 and theskin surface 16 causes the contact surface 15 to flex back to itsoriginal starting position. This provides for an over-center action toproduce a relatively large axial movement of the contact surface 15 outof the vial holder/outer housing 7. Axial movement of the contactsurface 15 allows for axial movement of the vial holder/outer housing 7,vial assembly 5, needle hub 8 and needle 3 until the needle 3 iscompletely retracted into the vial holder/outer housing 7, embedding theneedle 3 back into the needle shield 10, shielding it from the user.When the injector assembly 6 is pulled away from the skin surface 16,the bandage 13 peels away from the vial holder/outer housing 7 and isleft behind on the skin surface 16.

Referring to FIGS. 24-25, in this embodiment, the vial holder 7 and theouter housing 10 are joined by a flexible hinge 17. The injectorassembly 6, as seen in FIG. 25, has three relatively moveable that canpivot relative to one another including a vial holder 7, a needle hub 8,needle 21 and the outer housing 10. The vial assembly 5 is inserted intothe injector assembly 6 until snaps 20 in the vial holder 7 interfacewith the crimp cap 4 on the vial assembly 5 to prevent it from beingremoved. The vial holder 7 cannot advance relative to the outer housing10 as the safety pin 11 keeps it from advancing. The bottom of the outerhousing 10 is covered with an outer bandage cover 14.

Referring to FIGS. 26-27, the outer bandage cover 14 is removed from thebottom or base of the injector assembly 6. It is ready to be attached tothe skin surface 16. The double-sided tape 12 will provide the adhesionforce between the outer housing 10 and the skin surface 16. Once theinjector assembly 6 is placed on the skin surface 16, the safety pin 11is removed from the injector assembly 6 and it is ready for actuation.In FIG. 26, the user pushes down on the vial holder 7 to begin insertingthe needle 21 into the skin surface 16. Slight rotational movement ofthe vial holder 7, vial assembly 5, needle hub 8 and needle 21 (inunison) about the flexible hinge 17 continues until the needle hub 8bottoms out on the outer housing 10. In FIG. 27, the needle 21 andneedle hub 8 motion stop relative to the outer housing 10 just beforethe needle 21 is in communication with the fluid in the outerstopper/bladder 2. An additional small movement allows the needle 21 topierce the solid section of the inner plug 3 allowing communication ofthe needle 21 with the liquid 9 in the outer stopper/bladder 2. Thisallows for complete needle 21 travel into the skin surface 16 before thestart of dispense. The needle 21 enters the liquid space within a cutout19 in the inner plug 3. This small amount of motion also allows the ventneedle 15 to pierce the wall of the outer stopper/bladder 2 to allow forventing of the space between the outer stopper/bladder 2 and the insideof the vial 1.

Referring to FIGS. 28-29, once the needle 21 is in communication withthe liquid, substantially all of the liquid (preferably more than 95%and more preferably 99%) within the outer stopper/bladder 2 is dispensedinto the user. In FIG. 29, the dispense is completed and the user beginsto remove the injector assembly 6 by pulling up on the vial holder 7.The adhesion force between the double-sided tape 12 and the skin surface16 holds the outer housing 10 to the skin surface 16. Rotationalmovement about the flexible hinge 17 of the vial holder 7, vial assembly5, needle hub 8 and needle 21 (in unison) continues relative to theouter housing 10 until the needle 21 is completely retracted into theouter housing 10, shielding it from the user.

Referring to FIG. 30, at the end of the vial holder 7 travel relativethe outer housing 10, the injector assembly 6 is pulled away from theskin surface 16. The bandage 13 peels away from the outer housing 10 andis left behind on the skin surface 16.

Further Description Of Preferred Embodiment

Referring to FIGS. 31-32, a filling apparatus 29 such as a fillingneedle, vial adapter spike or other means of filling may be used tointroduce liquid 18 into the outer stopper/bladder 2 of the vialassembly 5. A filling apparatus 29 may have one or more slots 30integral to its body 32, and communicating with an internal fill paththat extends to a fill inlet that may be a luer port or other inlet. Toallow for filling of the outer stopper/bladder 2 of the vial assembly 5using a filling apparatus 29, one and preferably two or more inner seals31 may be configured into the inner stopper or plug 3 to interface withthe body or shaft 32 of the filling apparatus 29 during filling andsubsequent removal of the body 32 of the filling apparatus 29.Alternatively or additionally, multiple inner seals 31 may be configuredwith an axial spacing to cover the slot 30 of the body 32 of the fillingapparatus 29 to prevent loss of internal pressure or liquid 18 withinthe outer stopper/bladder 2 during the filling process. Alternatively oradditionally, multiple inner seals 31 may be configured with an axialspacing to prevent communication between the internal space of the outerstopper/bladder 2 and the ambient environment resulting in loss ofpressure or liquid 18 through the slot 30 of the body 32 of the fillingapparatus 29 during retraction after filling. In FIG. 32, the tip 33 ofthe filling apparatus 29 is shown fully inserted into the inner plug 3.The filling apparatus 29 is in communication with the outerstopper/bladder 2 and the inner seals 31 prevent loss of internalpressure or liquid 18 within the outer stopper/bladder 2 for sealing thepressure in the bladder as the fill apparatus or spike is retracted outof the filled pressurized bladder volume while maintaining a sealbetween the spike and ambient pressure. Specifically, the distance orzone between two inner seals is greater than the length of slots 30,whereby the fill apparatus or spike is sealed at at least one location,such as proximal to the slots or distal to the slots, as the spike isinserted or retracted.

Referring to FIGS. 33-34, the filling apparatus 29 is partiallywithdrawn from the inner plug 3 of the vial assembly 5. The fillingapparatus 29 is in communication with the outer stopper/bladder 2. Thetop of the slot 30 of the body 32 of the filling apparatus 29 is coveredby the upper inner seal 31 to prevent loss of internal pressure orliquid 18 within the outer stopper/bladder 2 during withdraw of thefilling apparatus. In FIG. 34, the filling apparatus 29 is furtherwithdrawn from the inner plug 3 of the vial assembly 5. The top of theslot 30 of the body 32 of the filling apparatus 29 is exposed to theambient environment but the tip 33 of the filling apparatus 29 is sealedby the lower inner seal 31. This prevents communication between thefilling apparatus 29 and outer stopper/bladder 2 and thus prevents lossof internal pressure or liquid 18 within the outer stopper/bladder 2during withdraw of the filling apparatus 29.

The foregoing description contains numerous independent concepts,features and functions that have utility and may be claimed separatelyand in combination with other concepts, features or functions,including, without limitation:

(1) a vial with resilient inner bladder for containing a drug,antibiotic or other medical liquid injectable and a pre-stress memberwithin the bladder;

(2) a method of making, filling and using such a vial;

(3) a vial injection assembly for injecting the contents of such apre-filled vial into a patient;

(4) the combination of such a vial injection assembly and pre-filledvial; and

(5) a method of injecting the contents of a pre-filled vial through theskin of a patient;

(6) a vial subassembly comprising a resilient bladder and a pre-stressmember within the bladder; and

(7) a slotted fill apparatus or spike in combination with pluralinternal vial seals that define a seal zone between the seals longerthan the spike slots(s) to seal the bladder during insertion andwithdrawal of the spike.

The foregoing concepts are useful and may be claimed alone or with oneor more of the other above concepts and/or with other features orfunctions described herein, including, without limitation, featuresand/or functions that:

(A) provide for injection of substantially all the vial contents,preferably at least 95% and more preferably at least 99%;

(B) provide for injection of most of the vial contents at substantiallyconstant flow rates;

(C) provide for sequential steps or stages in the injection assembly foradvancing a vial from a loading configuration to an injectionconfiguration;

(D) protect an injection needle against inadvertent needle sticks;

(E) prevent reuse of the injection assembly;

(F) automatically provide a bandage at the site of the injection;

(G) provide an injection without substantial user discomfort;

(H) vent displacement air into a vial between a pre-filled bladder andvial housing during injection;

(I) retain the injection assembly on the skin of a patient until removedby the user;

(J) permit filling of an internal vial bladder either manually or bylarge scale filling equipment;

(K) allow pre-stress of the vial bladder to be changed by changing thesize or configuration of a pre-stress member located within the bladder;and/or

(L) provide any combination of the above concepts and/or features orfunctions.

1. A medical fluid vial comprising: a housing having an open mouth atone end; a resilient bladder disposed with the housing for receiving amedical liquid, the bladder being resilient between an unfillednon-pressurized condition and a filled pressurized condition; apre-stress member located within the bladder, the pre-stress memberhaving a size larger that the size of the bladder in a non-pressurizedcondition; and wherein the bladder and/or pre-stress member normallyseal the vial mouth.
 2. The medical fluid vial of claim 1 in which thebladder and pre-stress member are configured to expel, upon opening,substantially all of the contents of the bladder.
 3. The medical fluidvial of claim 1 in which the bladder and pre-stress member areconfigured such that most of the liquid in the bladder is expelled at asubstantially constant flow rate.
 4. The medical fluid vial of claim 1in which the size or shape of the pre-stress member may be selectivelyvaried to change the amount of pre-stress on the bladder.
 5. The medicalfluid vial of claim 1 in which the bladder has a mouth and thepre-stress member is sealed within the bladder mouth.
 6. A componentsubassembly for a medical fluid vial, the component subassemblycomprising: a resilient bladder for receiving a medical fluid, thebladder being resilient between an unfilled non-pressurized conditionand a filled pressurized condition; and a pre-stress member disposedwithin the bladder and having a size larger than the bladder volume inthe unfilled non-pressurized condition.
 7. The component subassembly ofclaim 6 in which the size of the pre-stress member may be selectivelyvaried to change the amount of pre-stress on the bladder in the unfillednon-pressurized condition.
 8. The component subassembly of claim 6 inwhich the bladder has a mouth and the pre-stress member is sealed withinthe bladder mouth.
 9. The component subassembly of claim 6, in which thebladder and pre-stress member are configured to expel, upon opening,substantially all of the contents of the bladder.
 10. The componentsubassembly of claim 6 in which the bladder and pre-stress member areconfigured such that most of the liquid in the bladder is expelled at asubstantially constant flow rate.
 11. A vial injection assembly forinjecting the contents of a medical fluid vial containing pressurizedmedical liquid, the assembly including a vial holder portion, a housingportion mounting a vial access member and an injection needle that arein fluid communication, the holder portion and housing being relativelymovable between an initial vial loading position and an injectionposition in which the access member accesses the contents of the vialand the injection needle extends from the housing sufficiently to injectthe vial contents through the skin of a patient, and relatively movablefrom the injection position to a final position in which the housingshields the needle to prevent inadvertent needle sticks and cooperateswith the needle to prevent non-destructive reuse of the assembly. 12.The vial injection assembly of claim 11 including a skin-contactingsurface including an adhesive to temporarily retain the vial injectionassembly to the skin of a patient.
 13. The vial injection assembly ofclaim 11 including a removable bandage covering the injection site andseparable from the injection assembly upon removal of the assembly fromthe skin of a patient, such that the bandage remains on the patient'sskin and over the injection site.
 14. The vial injection assembly ofclaim 11 configured to displace the injection needle in the finalposition into interference with the housing to prevent non-destructivemovement of the needle from the final position to the injectionposition.
 15. The vial injection assembly of claim 11 including amedical fluid vial.